Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01512771 · ClinicalTrials.gov registry record
The Effect of Nasal Continuous Positive Airway Pressure Treatment on PTSD Symptoms.
A clinical trial of Anxiety and Post Traumatic Stress Disorder, sponsored by Northport Veterans Affairs Medical Center.
- Completed
- Registry status
- 18
- Enrollment target
- 1
- Study location
NCT01512771: Completed study of Anxiety and Post Traumatic Stress Disorder, sponsored by Northport Veterans Affairs Medical Center.
NCT01512771 is a study of Anxiety and Post Traumatic Stress Disorder that has completed, run by Northport Veterans Affairs Medical Center. The registered enrollment target is 18 participants, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01512771, a study of Anxiety and Post Traumatic Stress Disorder, has completed, sponsored by Northport Veterans Affairs Medical Center.
- COMPLETED
- Registry status
- 18 participants
- Enrollment target
- 1
- Study location
Study Summary
We hypothesize that prevention of Sleep Disordered Breathing among PTSD patients with nasal CPAP will result improve their anxiety, insomnia and alcohol craving (among those who use alcohol to control their symptoms).
Primary Outcome
A comparison of the effectiveness of six weeks of nasal CPAP plus usual care to usual care alone at decreasing the symptoms of PTSD (anxiety, insomnia and alcohol craving) among veterans with PTSD and SDB
Conditions Studied
Interventions
- OTHER CPAP
Study Locations (1)
New York
- PTSD unit at Northport VAMC - Northport
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2010-03 |
| Est. Completion | 2014-08 |
What the finished NCT01512771 record still lists
NCT01512771 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 18 participants, a relatively small participant target, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (96% lower).
The record links to 4 conditions, with Anxiety appearing as the primary indexed condition, and to 1 intervention - of which CPAP is the first listed.
NCT01512771 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT01512771 about?
NCT01512771 is a clinical study titled "The Effect of Nasal Continuous Positive Airway Pressure Treatment on PTSD Symptoms.". We hypothesize that prevention of Sleep Disordered Breathing among PTSD patients with nasal CPAP will result improve their anxiety, insomnia and alcohol craving (among those who use alcohol to control their symptoms).
What is the current status of trial NCT01512771?
This trial is currently completed. The enrollment target is 18 participants. The study started on 2010-03. Estimated completion is 2014-08.
What conditions does trial NCT01512771 study?
This clinical trial studies the following conditions: Anxiety, Post Traumatic Stress Disorder, Nightmares, Unrefreshed Sleep.
What interventions are being tested in trial NCT01512771?
The interventions under investigation include: CPAP (OTHER).
Who is sponsoring clinical trial NCT01512771?
This trial is sponsored by Northport Veterans Affairs Medical Center, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01512771 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anxiety
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01512771's enrollment target sits among peer trials
18 334th of 364 higher than 27 of 364 other Anxiety trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Anxiety trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Acute and Long-Term Antidepressant Treatment Success in Adolescents With Anxiety (AtLAS-A)
RECRUITING · Phase 4
-
Focused Ultrasound for the Complex Patient
RECRUITING · NA
-
Digital Intervention for Physical Activity
RECRUITING · NA
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
Brief Interventions for Coping with Distress
RECRUITING · NA
-
Personalized Feedback Intervention for Latinx Drinkers With Anxiety
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01245179 · 18 participants · Phase 1
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
- NCT01999361 · 18 participants · NA
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
- NCT02359825 · 18 participants · Phase 1
Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function
- NCT02870244 · 18 participants · Phase 1
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia